These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12691827)

  • 1. Expression of heparanase in human tumor cell lines and human head and neck tumors.
    Simizu S; Ishida K; Wierzba MK; Sato TA; Osada H
    Cancer Lett; 2003 Apr; 193(1):83-9. PubMed ID: 12691827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
    Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
    Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells.
    de Mestre AM; Rao S; Hornby JR; Soe-Htwe T; Khachigian LM; Hulett MD
    J Biol Chem; 2005 Oct; 280(42):35136-47. PubMed ID: 16093249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase messenger RNA expression in epithelial ovarian tumor.
    Kodama J; Shinyo Y; Hashen G; Hongo A; Yoshinouchi M; Hiramatsu Y
    Int J Mol Med; 2003 Dec; 12(6):961-4. PubMed ID: 14612974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
    Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
    J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
    Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
    Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer.
    Shinyo Y; Kodama J; Hongo A; Yoshinouchi M; Hiramatsu Y
    Ann Oncol; 2003 Oct; 14(10):1505-10. PubMed ID: 14504050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human heparanase: a molecular determinant of brain metastasis.
    Marchetti D; Nicolson GL
    Adv Enzyme Regul; 2001; 41():343-59. PubMed ID: 11384754
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
    Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
    Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.
    Cohen-Kaplan V; Doweck I; Naroditsky I; Vlodavsky I; Ilan N
    Cancer Res; 2008 Dec; 68(24):10077-85. PubMed ID: 19074873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.
    Doweck I; Kaplan-Cohen V; Naroditsky I; Sabo E; Ilan N; Vlodavsky I
    Neoplasia; 2006 Dec; 8(12):1055-61. PubMed ID: 17217623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase as a molecular target of cancer chemotherapy.
    Simizu S; Ishida K; Osada H
    Cancer Sci; 2004 Jul; 95(7):553-8. PubMed ID: 15245589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
    Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
    Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase expression of glioma in human and animal models.
    Hong X; Nelson KK; deCarvalho AC; Kalkanis SN
    J Neurosurg; 2010 Aug; 113(2):261-9. PubMed ID: 19835469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research advancement on heparanase in tumor metastasis].
    Li ZH; Yang SM
    Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis.
    Theodoro TR; de Matos LL; Sant Anna AV; Fonseca FL; Semedo P; Martins LC; Nader HB; Del Giglio A; da Silva Pinhal MA
    Neoplasia; 2007 Jun; 9(6):504-10. PubMed ID: 17603633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.